Facebook
X
LinkedIn
ForwardFSR Sarcoidosis Journal Club
June 15, 2026
The FSR Sarcoidosis Journal Club helps to improve patient care by incorporating evidence into clinical practice, by sharing advancements in sarcoidosis patient care, and increasing awareness of current research findings.
The article to be discussed, Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis, highlights the potential role environmental air pollution, specifically fine particulate matter, may play in the severity and progression of patients living with pulmonary sarcoidosis. Patient data from the US and Canada was analyzed and compared to determine the effects of long-term air pollution exposure on lung function over time. The article will be presented and discussed by pulmonologists with expertise in sarcoidosis and a senior researcher who has expertise in air pollution modeling. A Q&A will take place following the presentations.
Article to be Discussed:
Kim SE, Assayag D, Broerman M, Chen X, Fisher JH, Gibson KF, Johannson KA, Kass DJ, Khalil N, Kolb MRJ, Manganas H, Marcoux V, Ryerson CJ, Seedahmed MI, Zhang Y, Nouraie SM, Goobie GC. Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis. Am J Respir Crit Care Med. 2025 Oct;211(10):1846-1854. doi: 10.1164/rccm.202410-1925OC. PMID: 40532040.
The article to be discussed, Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis, highlights the potential role environmental air pollution, specifically fine particulate matter, may play in the severity and progression of patients living with pulmonary sarcoidosis. Patient data from the US and Canada was analyzed and compared to determine the effects of long-term air pollution exposure on lung function over time. The article will be presented and discussed by pulmonologists with expertise in sarcoidosis and a senior researcher who has expertise in air pollution modeling. A Q&A will take place following the presentations.
Article to be Discussed:
Kim SE, Assayag D, Broerman M, Chen X, Fisher JH, Gibson KF, Johannson KA, Kass DJ, Khalil N, Kolb MRJ, Manganas H, Marcoux V, Ryerson CJ, Seedahmed MI, Zhang Y, Nouraie SM, Goobie GC. Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis. Am J Respir Crit Care Med. 2025 Oct;211(10):1846-1854. doi: 10.1164/rccm.202410-1925OC. PMID: 40532040.
Target Audience
The intended audience includes general practitioners, pulmonologists, rheumatologists, and all specialties working with sarcoidosis as well as clinician researchers working on this topic.
Learning Objectives
Upon completion of this course, participants will be able to:
- Describe the relationship between air pollution, particulate matter exposure and their effects on lung function in patients living with sarcoidosis;
- Identify potential sources of pollution that contribute to sarcoidosis;
- Evaluate the clinical implications of air pollution exposure in pulmonary sarcoidosis.
You may also be interested in
Virtual
United States
WANT TO KNOW MORE?
For more information, contact Julie Collins via e-mail.
ACCESSIBILITY The University of Chicago is committed to providing leqal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact us via email.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
FACULTY
James Crooks, PhD, MS
Lisa Maier, MD, MSPH, FCCP, ATSF
Mark Mallozzi, MD, MPH
Lisa Maier, MD, MSPH, FCCP, ATSF
Mark Mallozzi, MD, MPH
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and The Foundation for Sarcoidosis Research. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and The Foundation for Sarcoidosis Research. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit-claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Registration: For more information, click the button below!
Claiming Credit: Enter the access code to unlock the credit-claiming process.
Please note: The credit-claiming process will close 30 days after the activity ends. Requests to claim credit after 30 days may incur additional fees.
Please login or create an account to proceed.